Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
The combination of collagen hydrolysate and chicken extract, specifically designated as EC-HC-II, is a nutraceutical product developed by Suntory Beverage and Food Asia. The formulation consists of 2.0 g of hydrolyzed collagen type II (HC-II) derived from chicken sternal cartilage and 5.81 g of chicken essence (EC), which is a water-extracted concentrate of chicken meat containing proteins and peptides. The HC-II component is a naturally occurring composite that includes collagen hydrolysate (66.5%), depolymerized chondroitin sulfate (18%), and hyaluronic acid (11%). This combination has been investigated for its potential to support joint, bone, and muscle functions, particularly in patients with knee osteoarthritis, by providing structural building blocks and bioactive peptides for cartilage and connective tissue maintenance.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on collagen hydrolysate + chicken extract.